Dr Lal Pathlabs has informed that it has attached a copy of Company's Q3 & 9M FY20 Earnings Presentation, which the Company proposes to share with Analysts/ Investors with respect to its Unaudited Financial Results (Standalone and Consolidated) for the Quarter & Nine months ended December 31, 2019, approved by the Board of Directors in their meeting held on February 3, 2020.
The above information is a part of company’s filings submitted to BSE.